<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6754462\results\search\tropicalVirus\results.xml">
  <result pre="Reports2045-2322Nature Publishing Group UKLondon pmcid: 675446250135 doi: 10.1038/s41598-019-50135-x : Article" exact="Dengue" post="virus infection in people residing in Africa: a systematic"/>
  <result pre="this systematic review and meta-analysis to determine the prevalence of" exact="DENV" post="infection in Africa. We searched PubMed, EMBASE, African Journals"/>
  <result pre="of bias. In apparently healthy individuals, the pooled prevalence of" exact="DENV" post="was 15.6% (95% confidence interval 9.9–22.2), 3.5% (0.8–7.8), and"/>
  <result pre="the distribution between different regions of Africa. The prevalence of" exact="DENV" post="infection is high in the African continent. Dengue fever"/>
  <result pre="prevalence of DENV infection is high in the African continent." exact="Dengue" post="fever therefore deserves more attention from healthcare workers, researchers,"/>
  <result pre="from healthcare workers, researchers, and health policy makers. Subject terms" exact="Dengue" post="virus Viral infection Epidemiology Introduction The incidence of dengue"/>
  <result pre="worldwide among which 96 million (25%) clinically manifest the disease1." exact="DENV" post="is one of the most common arboviruses. It is"/>
  <result pre="arboviruses. It is a tropical and subtropical mosquito bone-viral disease2,3." exact="DENV" post="is transmitted by two main epidemic vectors: Aedes aegypti"/>
  <result pre="water supply, sewer, poor waste management system, and international travel2,3." exact="DENV" post="infection is asymptomatic in more than 50% of cases"/>
  <result pre="no treatment for dengue infection. The main method of controlling" exact="DENV" post="transmission is through the active monitoring and surveillance of"/>
  <result pre="Before 1970, only 9 countries had experienced severe dengue epidemics." exact="Dengue" post="fever is now endemic in more than 100 countries"/>
  <result pre="date there is no study accurately investigating the epidemiology of" exact="DENV" post="infection among febrile and apparently healthy populations in this"/>
  <result pre="and meta-analysis with the aim to determine the prevalence of" exact="DENV" post="infection in Africa. This review would help better characterize"/>
  <result pre="considered observational studies (cross-sectional, case-control, and cohort). Studies in which" exact="DENV" post="infection were imported were excluded. Studies had to be"/>
  <result pre="excluded. Studies had to be conducted out of outbreak periods." exact="DENV" post="infection had to be diagnosed by the detection of"/>
  <result pre="diagnosed by the detection of the three biological markers of" exact="DENV" post="including RNA, Immunoglobulins (Ig) M, or G; among people"/>
  <result pre="Medicus was conducted to identify all relevant articles published on" exact="DENV" post="infection among people living in Africa from January 1st,"/>
  <result pre="data as recommended by Barendregt and colleagues14. The prevalence of" exact="DENV" post="infection has been recalculated on the basis of crude"/>
  <result pre="participants were included in the 76 studies. The prevalence of" exact="DENV" post="infection varied widely depending on clinical presentation and biomarkers"/>
  <result pre="(Fig. 2; Table 1). Sensitivity analysis considering only study with" exact="DENV" post="infection confirmation by PNRT test yielded findings in the"/>
  <result pre="neutralization test. Figure 2 Meta-analysis of immunoglobulins G seroprevalence of" exact="Dengue" post="virus in Africa. The prevalence of IgM seroprevalence in"/>
  <result pre="Table 1). Figure 3 Meta-analysis of immunoglobulins M seroprevalence of" exact="Dengue" post="virus in Africa. The DENV RNA prevalence in febrile"/>
  <result pre="of immunoglobulins M seroprevalence of Dengue virus in Africa. The" exact="DENV" post="RNA prevalence in febrile participants 8.4% (95%CI 3.7–14.4) was"/>
  <result pre="p &amp;lt; 0.0001 (Fig. 4; Table 1). Figure 4 Meta-analysis prevalence of" exact="Dengue" post="virus ribonucleic acid in Africa. We found substantial heterogeneity"/>
  <result pre="in sub-regions of africa There was a wide variation of" exact="DENV" post="infection prevalence between sub-regions in Africa. There was difference"/>
  <result pre="prevalence between sub-regions in Africa. There was difference in the" exact="DENV" post="infection IgG seroprevalence between regions for participants with fever,"/>
  <result pre="Africa; Supplementary Fig. 6). There was a difference in the" exact="DENV" post="infection IgG seroprevalence between regions in apparently healthy participants,"/>
  <result pre="This first systematic review with meta-analysis of the prevalence of" exact="DENV" post="infection among people residing in Africa depicted a relatively"/>
  <result pre="of seroprevalence between IgG and IgM. In addition, RNA of" exact="DENV" post="was not considered. The high prevalence we found in"/>
  <result pre="of urbanization in the continent can also explain the high" exact="DENV" post="infection prevalence. Indeed, high urbanization rate with poor infrastructure"/>
  <result pre="tropical and subtropical regions is associated with high burden of" exact="DENV" post="infection2,3. The mechanism would be the increase of mosquitoes"/>
  <result pre="favor the expansion of dengue vectors in Africa25–28. One of" exact="DENV" post="vectors, Aedes albopictus, originally came from tropical and subtropical"/>
  <result pre="IgG and IgM production), especially in the endemic context for" exact="DENV" post="like Africa. During a new acute infection (a second"/>
  <result pre="are needed to deeply investigate the heterogeneity of epidemiology of" exact="DENV" post="infection between and within countries of the continent. It"/>
  <result pre="It would be better to have the geospatial distribution of" exact="DENV" post="vectors in the continent to better understand the distribution"/>
  <result pre="vectors in the continent to better understand the distribution of" exact="DENV" post="infection among humans. Heterogeneity in the prevalence of dengue"/>
  <result pre="rates below 1% and there is no specific treatment against" exact="DENV" post="infection7. It would be also interesting to explore the"/>
  <result pre="also interesting to explore the implementation of routine diagnostic of" exact="DENV" post="infection in endemic countries with the aim to make"/>
  <result pre="Africa, it will be difficult to implement routine diagnostic of" exact="DENV" post="infection at a large scale as most of countries"/>
  <result pre="Our findings call for cost-effective strategies to curb the burden" exact="DENV" post="infection in Africa since severe dengue fever can rapidly"/>
  <result pre="in primary studies, include the difference in the prevalence of" exact="DENV" post="in vectors, the difference in the immunity of humans,"/>
  <result pre="first review with meta-analysis summarizing data on the epidemiology of" exact="DENV" post="infection in febrile and apparently healthy populations living in"/>
  <result pre="that of sensitivity analysis considering only studies with PNRT for" exact="DENV" post="confirmation; highlighting the robustness of our findings. We can"/>
  <result pre="our findings. We can definitely conclude that the prevalence of" exact="DENV" post="infection is high in the African continent although this"/>
  <result pre="the 70 year historyTrends in microbiology20142213814610.1016/j.tim.2013.12.01124468533 5.GuoCet al.Global Epidemiology of" exact="Dengue" post="Outbreaks in 1990–2015: A Systematic Review and Meta-AnalysisFrontiers in"/>
  <result pre="in Colombia (2000–2011): a systematic reviewPLoS Negl Trop Dis20159e000349910.1371/journal.pntd.000349925790245 7.WHO." exact="Dengue" post="and severe dengue, https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue (2019). 8.PabalanNet al.Associations of tumor"/>
  <result pre="of Aedes albopictus and Aedes aegypti in the Emergence of" exact="Dengue" post="and Chikungunya in Central AfricaVector-Borne and Zoonotic Diseases20101025926610.1089/vbz.2009.000519725769 29.KruegerAHagenRMShort"/>
  <result pre="albopictus and Aedes aegypti in the Emergence of Dengue and" exact="Chikungunya" post="in Central AfricaVector-Borne and Zoonotic Diseases20101025926610.1089/vbz.2009.000519725769 29.KruegerAHagenRMShort communication: First"/>
  <result pre="in endemic countriesWorld journal of virology2017691610.5501/wjv.v6.i1.928239567 38.Jaenisch, T. et al." exact="Dengue" post="expansion in Africa-not recognized or not happening? Emerg Infect"/>
  <result pre="recombinant tetravalent dengue vaccine: a meta-analysis of randomized trialsVaccine2014324885489210.1016/j.vaccine.2014.07.00825045816 40.WHO." exact="Dengue" post="control: Control strategies, https://www.who.int/denguecontrol/control_strategies/en/ (2019)."/>
 </snippets>
</snippetsTree>
